Eloxx Pharmaceuticals, Inc.
ELOX
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.59M | -4.34M | -6.23M | -6.32M | -7.51M |
| Total Depreciation and Amortization | 188.00K | 185.00K | 186.00K | 178.00K | 189.00K |
| Total Amortization of Deferred Charges | 50.00K | 47.00K | 120.00K | 144.00K | 139.00K |
| Total Other Non-Cash Items | 154.00K | 614.00K | 1.02M | 606.00K | 664.00K |
| Change in Net Operating Assets | -250.00K | 1.43M | -1.91M | -270.00K | -430.00K |
| Cash from Operations | -3.45M | -2.07M | -6.81M | -5.66M | -6.95M |
| Capital Expenditure | -- | -- | -- | 0.00 | -48.00K |
| Sale of Property, Plant, and Equipment | 233.00K | 14.00K | 11.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 233.00K | 14.00K | 11.00K | 0.00 | -48.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -220.00K | 0.00 | -7.50M | -- | -- |
| Issuance of Common Stock | 3.46M | 1.43M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 431.00K | -- | -- | 312.00K | 1.50M |
| Cash from Financing | 3.67M | 1.43M | -7.50M | 312.00K | 1.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 453.00K | -624.00K | -14.30M | -5.35M | -5.49M |